SCHEMBL20988136

SCHEMBL20988136

CCC(CC)NCCc1c[nH]c2ccccc12

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 5/20 0.66
HTR1A P08908 3/20 0.65
KDM4E B2RXH2 2/20 0.65
ALDH1A1 P00352 1/20 0.65
HTT P42858 1/20 0.65
MC5R P33032 1/20 0.59
MC3R P41968 1/20 0.59
MC1R Q01726 1/20 0.59
CYP1A2 P05177 2/20 0.57
MEN1 O00255 1/20 0.57
LMNA P02545 1/20 0.57
PKM P14618 1/20 0.57
TSHR P16473 1/20 0.57
CYP2C19 P33261 1/20 0.57
BLM P54132 1/20 0.57
KMT2A Q03164 1/20 0.57
G6PD P11413 1/20 0.55
HRH3 Q9Y5N1 1/20 0.54
HTR6 P50406 2/20 0.54
IDO1 P14902 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11828168 0.87 HTR2A (0.64) HTR2AHTR1AKDM4EALDH1A1HTT
SCHEMBL2732463 0.84 HTR2A (0.69) HTR2AHTR1AKDM4EALDH1A1HTT
SCHEMBL30536673 0.84 HTR2A (0.69) HTR2AHTR1AKDM4EALDH1A1HTT
Hydrochloric Acid SCHEMBL26688729 0.83 HTR2A (0.67) HTR2AHTR1AKDM4EALDH1A1HTT
Bromide SCHEMBL26186699 0.83 HTR2A (0.67) HTR2AHTR1AKDM4EALDH1A1HTT
SCHEMBL21781048 0.82 KDM4E (0.65) HTR2AHTR1AKDM4EALDH1A1HTT
SCHEMBL25076905 0.80 HTR2C (0.68) HTR2AHTR1AKDM4EALDH1A1CYP1A2
SCHEMBL1972829 0.80 HTR2A (1.00) HTR2AHTR1AKDM4EALDH1A1HTT
SCHEMBL15130901 0.79 KMT2A (0.74) HTR2AHTR1AKDM4EALDH1A1HTT
SCHEMBL13652758 0.79 KDM4E (0.61) HTR2AHTR1AKDM4EALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10696707-B2 Polyene macrolide derivative SHIONOGI & CO., LTD. (JP) 2020-06-30 US disclosed
US-20190135847-A1 POLYENE MACROLIDE DERIVATIVE SHIONOGI & CO., LTD. (JP) 2019-05-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190135847-A1 POLYENE MACROLIDE DERIVATIVE ERG28, RPL23, RPL10 HTR2A 3593/4885HTR1A 4001/4885KDM4E 1641/4885
US-10696707-B2 Polyene macrolide derivative ERG28, RPL23, RPL10 HTR2A 3593/4885HTR1A 4001/4885KDM4E 1641/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.